Induction Chemotherapy With an Anti-GD2 Monoclonal Antibody (Dinutuximab) and Cytokines in Children With Newly Diagnosed High-risk Neuroblastoma: A Case Series.

Gartrell, Jessica; Shulkin, Barry L; Helmig, Sara; Caldwell, Kenneth J; Furman, Wayne; Federico, Sara M

Gartrell, Jessica; Shulkin, Barry L; Helmig, Sara; Caldwell, Kenneth J; Furman, Wayne; Federico, Sara M.

Afiliação

Gartrell J; Department of Oncology, St Jude Children's Research Hospital.
Shulkin BL; University of Tennessee Health Science Center.
Helmig S; Department of Diagnostic Imaging.
Caldwell KJ; Developmental Biology & Solid Tumor Program, St Jude Children's Research Hospital, Memphis, TN.
Furman W; Department of Oncology, St Jude Children's Research Hospital.
Federico SM; Department of Oncology, St Jude Children's Research Hospital.

J Pediatr Hematol Oncol ; 43(5): e692-e696, 2021 07 01.

Article em En | MEDLINE | ID: mdl-33181583

Assuntos

Anticorpos Monoclonais/uso terapêutico; Antineoplásicos/uso terapêutico; Citocinas/uso terapêutico; Neuroblastoma/tratamento farmacológico; Pré-Escolar; Feminino; Humanos; Quimioterapia de Indução; Lactente; Masculino; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Anticorpos Monoclonais / Neuroblastoma / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Pediatr Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google